Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Diabetes Care Devices Market, by Product
1.4.2 Global Diabetes Care Devices Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansions
3.2.5 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements : 2018, Oct – 2022, May) Leading Players
Chapter 4. Global Diabetes Care Devices Market by Product
4.1 Global Insulin Delivery Devices Market by Region
4.2 Global Blood Glucose Monitoring Devices Market by Region
Chapter 5. Global Diabetes Care Devices Market by Region
5.1 North America Diabetes Care Devices Market
5.1.1 North America Diabetes Care Devices Market by Product
5.1.1.1 North America Insulin Delivery Devices Market by Country
5.1.1.2 North America Blood Glucose Monitoring Devices Market by Country
5.1.2 North America Diabetes Care Devices Market by Country
5.1.2.1 US Diabetes Care Devices Market
5.1.2.1.1 US Diabetes Care Devices Market by Product
5.1.2.2 Canada Diabetes Care Devices Market
5.1.2.2.1 Canada Diabetes Care Devices Market by Product
5.1.2.3 Mexico Diabetes Care Devices Market
5.1.2.3.1 Mexico Diabetes Care Devices Market by Product
5.1.2.4 Rest of North America Diabetes Care Devices Market
5.1.2.4.1 Rest of North America Diabetes Care Devices Market by Product
5.2 Europe Diabetes Care Devices Market
5.2.1 Europe Diabetes Care Devices Market by Product
5.2.1.1 Europe Insulin Delivery Devices Market by Country
5.2.1.2 Europe Blood Glucose Monitoring Devices Market by Country
5.2.2 Europe Diabetes Care Devices Market by Country
5.2.2.1 Germany Diabetes Care Devices Market
5.2.2.1.1 Germany Diabetes Care Devices Market by Product
5.2.2.2 UK Diabetes Care Devices Market
5.2.2.2.1 UK Diabetes Care Devices Market by Product
5.2.2.3 France Diabetes Care Devices Market
5.2.2.3.1 France Diabetes Care Devices Market by Product
5.2.2.4 Russia Diabetes Care Devices Market
5.2.2.4.1 Russia Diabetes Care Devices Market by Product
5.2.2.5 Spain Diabetes Care Devices Market
5.2.2.5.1 Spain Diabetes Care Devices Market by Product
5.2.2.6 Italy Diabetes Care Devices Market
5.2.2.6.1 Italy Diabetes Care Devices Market by Product
5.2.2.7 Rest of Europe Diabetes Care Devices Market
5.2.2.7.1 Rest of Europe Diabetes Care Devices Market by Product
5.3 Asia Pacific Diabetes Care Devices Market
5.3.1 Asia Pacific Diabetes Care Devices Market by Product
5.3.1.1 Asia Pacific Insulin Delivery Devices Market by Country
5.3.1.2 Asia Pacific Blood Glucose Monitoring Devices Market by Country
5.3.2 Asia Pacific Diabetes Care Devices Market by Country
5.3.2.1 China Diabetes Care Devices Market
5.3.2.1.1 China Diabetes Care Devices Market by Product
5.3.2.2 Japan Diabetes Care Devices Market
5.3.2.2.1 Japan Diabetes Care Devices Market by Product
5.3.2.3 India Diabetes Care Devices Market
5.3.2.3.1 India Diabetes Care Devices Market by Product
5.3.2.4 South Korea Diabetes Care Devices Market
5.3.2.4.1 South Korea Diabetes Care Devices Market by Product
5.3.2.5 Singapore Diabetes Care Devices Market
5.3.2.5.1 Singapore Diabetes Care Devices Market by Product
5.3.2.6 Malaysia Diabetes Care Devices Market
5.3.2.6.1 Malaysia Diabetes Care Devices Market by Product
5.3.2.7 Rest of Asia Pacific Diabetes Care Devices Market
5.3.2.7.1 Rest of Asia Pacific Diabetes Care Devices Market by Product
5.4 LAMEA Diabetes Care Devices Market
5.4.1 LAMEA Diabetes Care Devices Market by Product
5.4.1.1 LAMEA Insulin Delivery Devices Market by Country
5.4.1.2 LAMEA Blood Glucose Monitoring Devices Market by Country
5.4.2 LAMEA Diabetes Care Devices Market by Country
5.4.2.1 Brazil Diabetes Care Devices Market
5.4.2.1.1 Brazil Diabetes Care Devices Market by Product
5.4.2.2 Argentina Diabetes Care Devices Market
5.4.2.2.1 Argentina Diabetes Care Devices Market by Product
5.4.2.3 UAE Diabetes Care Devices Market
5.4.2.3.1 UAE Diabetes Care Devices Market by Product
5.4.2.4 Saudi Arabia Diabetes Care Devices Market
5.4.2.4.1 Saudi Arabia Diabetes Care Devices Market by Product
5.4.2.5 South Africa Diabetes Care Devices Market
5.4.2.5.1 South Africa Diabetes Care Devices Market by Product
5.4.2.6 Nigeria Diabetes Care Devices Market
5.4.2.6.1 Nigeria Diabetes Care Devices Market by Product
5.4.2.7 Rest of LAMEA Diabetes Care Devices Market
5.4.2.7.1 Rest of LAMEA Diabetes Care Devices Market by Product
Chapter 6. Company Profiles
6.1 F. Hoffmann-La Roche Ltd.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Partnerships, Collaborations, and Agreements:
6.1.5.2 Product Launches and Product Expansions:
6.2 DexCom, Inc.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional Analysis
6.2.4 Research & Development Expenses
6.2.5 Recent strategies and developments:
6.2.5.1 Partnerships, Collaborations, and Agreements:
6.2.5.2 Product Launches and Product Expansions:
6.2.5.3 Acquisition and Mergers:
6.3 Novo Nordisk A/S
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental & Regional Analysis
6.3.4 Research & Development Expenses
6.3.5 Recent strategies and developments:
6.3.5.1 Partnerships, Collaborations, and Agreements:
6.3.5.2 Acquisition and Mergers:
6.4 Sanofi S.A.
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.4.5 Recent strategies and developments:
6.4.5.1 Partnerships, Collaborations, and Agreements:
6.4.5.2 Product Launches and Product Expansions:
6.5 Zealand Pharma A/S (Valeritas, Inc.)
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Research & Development Expenses
6.5.4 Recent strategies and developments:
6.5.4.1 Product Launches and Product Expansions:
6.5.4.2 Approvals and Trials:
6.6 B. Braun Melsungen AG
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expenses
6.6.5 Recent strategies and developments:
6.6.5.1 Partnerships, Collaborations, and Agreements:
6.7 Bayer AG
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental and Regional Analysis
6.7.4 Research & Development Expense
6.7.5 Recent strategies and developments:
6.7.5.1 Partnerships, Collaborations, and Agreements:
6.7.5.2 Approvals:
6.8 Abbott Laboratories
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expense
6.8.5 Recent strategies and developments:
6.8.5.1 Partnerships, Collaborations, and Agreements:
6.8.5.2 Approvals:
6.9 Ypsomed AG
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental and Regional Analysis
6.9.4 Recent strategies and developments:
6.9.4.1 Partnerships, Collaborations, and Agreements:
6.10. Arkray, Inc.
6.10.1 Company Overview
6.10.2 Recent strategies and developments:
6.10.2.1 Partnerships, Collaborations, and Agreements:
6.10.2.2 Geographical Expansions:
Unique Offerings 